Intercure Ltd.
- Ticker
- INCR
- CIK
- 1857030
- Industry
- Pharmaceutical Preparations
Financials 2
Ownership 8
- 4 Statement of changes in beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- SC 13G Major Shareholders
Prospectus 6
- 424B3 Prospectus filed pursuant to Rule 424(b)(3)
- DRSLTR Correspondence Related to Draft Registration Statement
- DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
- DRSLTR Correspondence Related to Draft Registration Statement
- DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
- DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Other 103
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- 6-K/A Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- D Exempt (Private) Offering
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- 6-K/A Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments